Advertisements
Clopidogrel Bisulfate
| Price: | Contact for latest price |
|---|---|
| Minimum Order: | |
| Payment Terms: | TT |
| Port of Export: |
Product Details
| Model No.: | Brand Name: |
|---|
| Certification: | |
|---|---|
| Specification: | Clopidogrel Bisulfate |
Packaging & Delivery
| Packaging: | |
|---|---|
| Delivery/Lead Time: | |
| Production Capacity: |
Product Description
Lepu Medical Technology ( Beijing ) Co., Ltd was established in 1999. It is specialized in developing, manufacturing and marketing high-tech medical devices and equipment.
Today, Lepu Medical has grown into a global leading medical technology company in the fields of cardiovascular interventions, structural heart diseases, cardiac rhythm management, anesthesia and critical care, in vitro diagnostics and general surgery with products include coronary stents, dilatation balloon catheters, interventional accessories, occlusion devices, mechanical heart valves, electrophysiology catheters, pacemakers, in vitro diagnostic equipment and biomarkers, DSA systems and surgical staplers. In 2009 Lepu Medical successfully went public, and was listed on Chinext Shenzhen StockExchange Market ( stock code: 300003).
Clopidogrel Hydrogen Sulfate
Item/Code CAS No. Molecular Structure Therapeutic Area Certification/Stage
API 135046-48-9
120202-66-6 Thrombus
USA - USDMF No. 35081
Canada - MF No. 2020-150
CEP - Qualification in process
If you want to know more interventional medical device solutions, please visit our website.
Nowthe price of medical device is reasonable, if you have needs, please leave us a message.
|
SUPPLIER PROFILE
|
|||
|---|---|---|---|
| Company: | Lepu Medical Technology(Beijing)Co.,Ltd | ||
| City/State | Beijing, Beijing | Country: |
China 
|
| Business Type: | Export - Manufacturer / Trading Company | Established: | NA |
| Member Since: | 2021 | Contact Person | Steven Lu |
SUPPLIER PROFILE
City/State/Country -
Beijing, Beijing
China
Business Type -
Export - Manufacturer / Trading Company
Established -
NA
Member Since -
2021
Contact Person -
Steven Lu